Torres-Correa v. Instituto de Ojos y Piel, Inc

CourtDistrict Court, D. Puerto Rico
DecidedAugust 27, 2025
Docket3:23-cv-01025
StatusUnknown

This text of Torres-Correa v. Instituto de Ojos y Piel, Inc (Torres-Correa v. Instituto de Ojos y Piel, Inc) is published on Counsel Stack Legal Research, covering District Court, D. Puerto Rico primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Torres-Correa v. Instituto de Ojos y Piel, Inc, (prd 2025).

Opinion

THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF PUERTO RICO

GLADYS TORRES-CORREA, Plaintiff, v. INSTITUTO DE OJOS Y PIEL, INC., et | “iv: No. 23-cv-1025 (MAJ) al., Defendants.

OPINION AND ORDER I. Introduction This medical malpractice action is brought by Gladys Torres-Correa (“Plaintiff”) against Instituto de Ojos y Piel, Inc. and Dr. Miguel Santiago Garcia, along with several unnamed insurers. (“Defendants”). (ECF No. 1). After undergoing ophthalmic surgery performed by Defendants, Plaintiff allegedly developed a series of complications. (ECF No. 1 at 2 94 6-13). Plaintiff claims that those complications were caused by Defendants’ negligence. (ECF No. 1 at 2 414). To prove her claims, Plaintiff intends to introduce at trial the expert witness testimony of Dr. José A. Rodriguez Robles (“Dr. Rodriguez”). (ECF No. 53 at 23). Defendants move the Court to rule the proffered testimony of Dr. Rodriguez inadmissible. (ECF No. 57). Plaintiff filed responses to Defendants’ motion, (ECF No. 63, 64),! Defendants replied, (ECF No. 65, 66), and Plaintiff filed a sur-reply. (ECF

1 On April 30, 2025, Defendants filed two motions in limine relating to the prospective testimony of Dr. Rodriguez. (ECF No. 57, 58). In the first of those motions — the focus of the instant Opinion and Order — Defendants argue that the testimony of Dr. Rodgriguez should be ruled inadmissible due to his lack of qualifications and the unreliability of his expert report. (ECF No. 57). In the second motion, Defendants

No. 67). For the reasons provided below, Defendants’ motion to exclude the testimony of Dr. Rodríguez is GRANTED. II. Background Plaintiff suffers from glaucoma and cataracts. (ECF No. 1 at 1–2 ¶ 5); (ECF No. 9 at 2 ¶ 5). To treat those conditions, on May 12, 2020, Plaintiff underwent ophthalmic

surgery in her left eye. (ECF No. 1 at 1–2 ¶ 5); (ECF No. 9 at 2 ¶ 5). The surgery was performed by Defendant Dr. Miguel Santiago García at Instituto de Ojos y Piel. (ECF No. 1 at 1–2 ¶¶ 5, 7, 8); (ECF No. 9 at 2 ¶¶ 5, 7, 8); (ECF No. 53 at 17 ¶ 1). After the surgery, Plaintiff developed complications in her eye. (ECF No. 53 at 3, 8). In November 2020, she was diagnosed with “Complicated Cat [S]urgery OS with Corneal Scarring, Sphincter Damage Leaving Fixed Enlarged Pupil.” (ECF No. 1 at 2 ¶ 13); (ECF No. 9 at 3 ¶ 13). On January 20, 2023, Plaintiff filed the Complaint, alleging that Defendants were negligent in the diagnosis, treatment, and post-operative care of her condition. (ECF No. 1 at 2 ¶ 14). Plaintiff seeks two million dollars in damages. (ECF No. 1 at 4 ¶ 24). Plaintiff retained Dr. Rodríguez as an expert witness. (ECF No. 53 at 23). Dr.

Rodríguez is a neurologist. (ECF No. 53 at 23). Plaintiff proffers that Dr. Rodríguez will testify as to the “treatment provided to [Plaintiff] at Instituto de Ojos y Piel, . . . the applicable standards of care[,] . . . causation between the treatment provided . . . and the damages alleged[,] . . . [as well as] the opinions [of] Defendant’s expert.” (ECF No. 53 at 23–24). On March 13, 2022, Dr. Rodríguez prepared a report analyzing the events of this

argued that Dr. Rodriguez should be prohibited from testifying as to the opinions of Defendants’ expert. (ECF No. 58). On June 2, 2025, Plaintiff filed responses to those motions. (ECF No. 63, 64). Each filing states that it was filed in response to ECF No. 58. Although the Court lacks clarity on which brief was intended to respond to ECF No. 57, the Court will consider each of Plaintiff’s filings. case. (ECF No. 57-1).2 On June 28, 2024, Dr. Rodríguez was deposed by Defendants. (ECF No. 57-2).3 On February 20, 2025, Plaintiff produced to Defendants a second report prepared by Dr. Rodríguez. (ECF No. 58-3); (ECF No. 58 at 4) (collectively “the Reports”).4 In the Reports, Dr. Rodríguez concludes that Plaintiff suffered “permanent damage of the left cornea” as a result of “medical malpractice”, (ECF No. 57-1 at 2), and

that Defendants’ alleged failure to “ensure adequate post-operative follow-up” worsened her condition. (ECF No. 58-3 at 2). On May 20, 2025, Defendants filed the instant motion, requesting that the Court rule the proffered testimony of Dr. Rodríguez inadmissible. (ECF No. 57). Defendants provide four reasons for this request. First, Defendants argue that Dr. Rodríguez is unqualified to offer expert opinions regarding the medical issues in this case, given that he is not an ophthalmologist, has no formal training in the field, and has never performed the surgeries Plaintiff received in this case. (ECF No. 57 at 3). Second, Defendants assert that Dr. Rodríguez has failed to adequately describe what he believes to be the applicable standard of care in this case. (ECF No. 57 at 2–3). Third, Defendants contend that Dr.

2 An identical copy of the first report was filed at ECF 58-1. For consistency, the Court will cite only to 57-1 throughout this Opinion and Order. 3 When addressing the substance of Dr. Rodríguez’s expert opinion, the Court has also looked to his deposition testimony and treated that testimony as if it were included in the Reports. “Generally, Rule 26 does not allow parties to cure deficient expert reports by supplementing them with later deposition testimony[.]” Sandoval v. Hosp. Oriente, Inc., 770 F. Supp. 3d 412, 423 (D.P.R. 2025) (citations omitted). Yet exceptions to this general rule exist. See, e.g. Vargas-Alicea v. Cont'l Cas. Co., Civ. No. 15-1941, 2020 WL 3470325 (D.P.R. June 25, 2020) (considering deposition testimony where “Defendants deposed [the expert] in connection with his report and elicited responses that reasonably filled the report’s gaps as to standard of care, deviation, and causation,” after assessing whether such testimony was an unfair surprise or prejudicial to defendants). Because the Court finds that all testimony from Dr. Rodríguez is excludable on other grounds, the Court declines to specifically address whether the deposition testimony in this case is admissible. For the purposes of this Opinion and Order the Court assumes, without deciding, that the deposition testimony may be considered. 4 An identical copy of the second report was filed at ECF 64-2. For consistency, the Court will cite only to 58-3 throughout this Opinion and Order. The Court notes that it is not clear from the face of the second report whether that document was intended to serve as either a supplement or as a substitute to the original report. (ECF No. 58-3). For the avoidance of doubt, the Court has considered the contents of both reports. Rodríguez’s proffered testimony regarding causation is wholly conclusory and “outcome driven[.]” (ECF No. 57 at 10). Finally, Defendants assert that “Dr. Rodríguez’s report and his deposition testimony are devoid of any clinical evidence, specific findings or medical literature to support” his opinion. (ECF No. 57 at 10). III. The Expert Opinion

In the first report, Dr. Rodríguez articulated his medical opinion as follows: The intraocular surgery that was performed in this patient over the left eye provoke a permanent damage of the left cornea between others. The medical doctor stays away of the adequate standard of care in this case. Patient now is pending for heroic surgical procedure without any kind of guarantee to recover her vision in the left eye. The procedure will be on schedule for April 06, 2022. The iatrogenically induced complication on the left cataract surgery provoke the cornea decompensation that can be prevented (avoided) by physician if proper precautions are taken to avoid corneal failure. This patient will require corneal transplantation as heroic measure in order to try to recovery the vision by the left eye.

(ECF No. 57-1 at 2). In the first report, Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
General Electric Co. v. Joiner
522 U.S. 136 (Supreme Court, 1997)
United States v. Sepulveda
15 F.3d 1161 (First Circuit, 1993)
Nieves-Villanueva v. Soto-Rivera
133 F.3d 92 (First Circuit, 1997)
Mitchell v. United States
141 F.3d 8 (First Circuit, 1998)
Cummings v. Standard Register Co.
265 F.3d 56 (First Circuit, 2001)
United States v. Vargas
471 F.3d 255 (First Circuit, 2006)
United States v. Sevilla-Oyola
770 F.3d 1 (First Circuit, 2014)
Milward v. Rust-Oleum Corp.
820 F.3d 469 (First Circuit, 2016)
Rivera-Marrero v. Presbyterian Community Hospital
255 F. Supp. 3d 290 (D. Puerto Rico, 2017)
Pagés-Ramírez v. Ramírez-González
605 F.3d 109 (First Circuit, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
Torres-Correa v. Instituto de Ojos y Piel, Inc, Counsel Stack Legal Research, https://law.counselstack.com/opinion/torres-correa-v-instituto-de-ojos-y-piel-inc-prd-2025.